✦ LIBER ✦

191 Pemetrexed in combination with carboplatin in elderly patients with malignant pleural mesothelioma

✍ Scribed by Ceresoli, G.L.; Castagneto, B.; Zucali, P.A.; Favaretto, A.G.; Mencoboni, M.; De Giovanni, D.; Cortinovis, D.; Marangolo, M.; Grossi, F.; Del Conte, G.; Ceribelli, A.; Bearz, A.; Muzio, A.; Santoro, A.

Book ID: 118573874
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 48 KB
Volume: 54
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(07)70267-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pemetrexed plus carboplatin in elderly p

Pemetrexed plus carboplatin in elderly patients with malignant pleural mesothelioma: combined analysis of two phase II trials

✍ Bearz, A; Castagneto, B; Zucali, P A; Favaretto, A; Mencoboni, M; Grossi, F; Cor 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 135 KB

203 Pemetrexed in combination with carbo

203 Pemetrexed in combination with carboplatin for the treatment of patients with malignant mesothelioma

✍ Papi, M.; Genestreti, G.; Tassinari, D.; Tamburini, E.; Nicolini, M.; Fabbri, P. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 37 KB

Retreatment with pemetrexed-based chemot

Retreatment with pemetrexed-based chemotherapy in patients with malignant pleural mesothelioma

✍ Ceresoli, Giovanni L.; Zucali, Paolo A.; De Vincenzo, Fabio; Gianoncelli, Letizi 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 199 KB

Significant response to carboplatin/peme

Significant response to carboplatin/pemetrexed chemotherapy in malignant pleural mesothelioma

✍ Fullam, L.; Carney, D.; McCaffrey, J. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Gemcitabine and vinorelbine in pemetrexe

Gemcitabine and vinorelbine in pemetrexed-pretreated patients with malignant pleural mesothelioma

✍ Paolo A. Zucali; Giovanni L. Ceresoli; Isabella Garassino; Fabio De Vincenzo; Ra 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB

## Abstract ## BACKGROUND Pemetrexed‐cisplatin chemotherapy is the standard of care in the first‐line treatment of unresectable malignant pleural mesothelioma (MPM). Second‐line cytotoxic therapy is considered for a growing group of patients, but the optimal treatment has not been defined to date.

Gemcitabine combined with carboplatin in

Gemcitabine combined with carboplatin in patients with malignant pleural mesothelioma : A multicentric Phase II study

✍ Adolfo G. Favaretto; Savina M. L. Aversa; Adriano Paccagnella; Vincenzo De Pangh 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 1 views

## Abstract ## BACKGROUND Malignant pleural mesothelioma (MPM) is increasing rapidly worldwide. Currently, pemetrexed plus cisplatin chemotherapy showed a survival advantage versus cisplatin alone. No impact on patient survival of surgery, radiotherapy, or their combination has been demonstrated.